FAQ/Help |
Calendar |
Search |
Today's Posts |
|
12-08-2014, 10:49 AM | #1 | ||
|
|||
Member
|
The retrospective analysis encouraged the European scientists, including Barker and Björklund, to launch a new trial, which is funded by the European Union, involving fetal dopaminergic-neuron transplants. Known as TRANSEURO, it will monitor disease progression in 150 patients in the United Kingdom, Sweden, France and Germany. The first patient is due for transplantation next month at Addenbrooke’s Hospital in Cambridge. In line with the retro*spective findings, the average age of trial participants at recruitment was 55, and their average disease duration just 4 years.
http://www.nature.com/news/fetal-cel...nson-s-1.15387 |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Stem Cell human trials to begin soon! | Parkinson's Disease | |||
Stem cell transplants for Parkinson’s disease edging closer (rat studies) | Parkinson's Disease | |||
Scientists develop human stem cell disease model of Parkinson's disease in a dish | Parkinson's Disease | |||
Adult Stem Cell Research Reverses Effects of Parkinson's Disease in Human Trial | Parkinson's Disease | |||
Stem cell studies | Multiple Sclerosis |